Rezolve Ai challenges Commerce.com board’s rejection of takeover bid
Rezolve Ai (NASDAQ:RZLV) issued a sharp rebuttal on April 9, 2026, following the rejection of its acquisition proposal by the Board of Directors of Commerce.com (NASDAQ:CMRC).
Todas as matérias desta categoria, das mais recentes às mais antigas.
Rezolve Ai (NASDAQ:RZLV) issued a sharp rebuttal on April 9, 2026, following the rejection of its acquisition proposal by the Board of Directors of Commerce.com (NASDAQ:CMRC).
The Walt Disney Company (NYSE:DIS) is preparing to eliminate as many as 1,000 positions over the coming weeks, according to reports from The Wall Street Journal and Variety.
Terra Quantum, a leading European "quantum-as-a-service" provider, announced on April 9, 2026, that it has signed a non-binding letter of intent (LOI) to merge with Mountain Lake Acquisition Corp. II (NASDAQ:MLAA).
Invivyd (NASDAQ:IVVD), a biopharmaceutical company specializing in infectious diseases, announced on April 9, 2026, a strategic expansion of its ongoing Phase 3 clinical trial alongside significant progress in its respiratory and viral pipeline.
SUNation Energy (NASDAQ:SUNE), a provider of solar energy and storage solutions, announced on April 9, 2026, that its Board of Directors has authorized a formal review of strategic alternatives.
Northern Technologies International (NASDAQ:NTIC), a developer of corrosion inhibiting solutions and bio-based polymer resins, reported on April 9, 2026, that consolidated net sales for its fiscal second quarter rose 15.3% to $22 million.
Byrna Technologies (NASDAQ:BYRN), a leader in less-lethal personal defense technology, reported its fiscal first-quarter 2026 results on April 9, 2026, marking a period of strategic leadership transition and significant brick-and-mortar growth.
The Simply Good Foods Company (NASDAQ:SMPL) reported a challenging second quarter for fiscal 2026 on April 9, 2026, headlined by a significant net loss and a downward revision of its full-year financial outlook.
C4 Therapeutics (NASDAQ:CCCC) announced on April 9, 2026, a significant expansion of its decade-long relationship with Roche, entering into a new collaboration to advance the emerging field of Degrader-Antibody Conjugates (DACs).
Chevron (NYSE:CVX) and project operator Occidental announced on April 9, 2026, a significant oil discovery at the Bandit prospect, located in the deepwater Gulf of America.
Galmed Pharmaceuticals (NASDAQ:GLMD) announced on April 9, 2026, a significant technological breakthrough with the development of a brain-penetrating formulation of its lead compound, Aramchol.
ImmunityBio (NASDAQ:IBRX), a commercial-stage biotechnology firm, reported on April 9, 2026, that preliminary net product revenue for the first quarter reached approximately $44.2 million.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade